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Pulmonary epithelioid haemangioendothelioma
— interferon 2-alpha treatment — case report
Płucny haemangioendothelioma epithelioides — leczenie interferonem 2-alfa
— opis przypadku
Streszczenie
W pracy przedstawiono przypadek 62-letniej chorej, otyłej palaczki tytoniu (10 paczko/lat), przyjętej do Instytutu Gruźlicy i Chorób Płuc
w Warszawie w celu diagnostyki stwierdzanych w badaniu radiologicznym klatki piersiowej dobrze wysyconych cieni okrągłych.
Zmiany te były widoczne w badaniach radiologicznych od 5 lat, jednak w ostatnim okresie uległy zdecydowanemu powiększeniu.
Chora leczyła się z powodu nadciśnienia tętniczego, cukrzycy insulinoniezależnej oraz łuszczycy z zajęciem skóry. W chwili przyjęcia
uskarżała się na kaszel z niewielkim odkrztuszaniem śluzowej wydzieliny i okresowe bóle kostno-stawowe. W badaniu przedmioto-
wym stwierdzono zmiany skórne o charakterze łuszczycowym, niewielkie obrzęki na kończynach dolnych oraz palce pałeczkowate.
Odczyn tuberkulinowy był dodatni. W badaniu tomograficznym klatki piersiowej wykazano obecność częściowo uwapnionych
guzków o średnicy około 1 cm zlokalizowanych głównie w dolnych i środkowych polach płucnych bez powiększenia węzłów
chłonnych wnęk i śródpiersia. Badaniem histologicznym wycinków uzyskanych drogą biopsji otwartej płuca stwierdzono obec-
ność w obrębie pęcherzyków i naczyń płucnych nacieku nowotworu pochodzenia naczyniowego. Komórki tego guza wykazywały
obecność antygenów: czynnika VIII, CD31 i CD34, co pozwoliło postawić rozpoznanie haemangioendothelioma epithelioides płuc.
Po 6 miesiącach od biopsji otwartej płuca doszło do istotnej progresji choroby, co było powodem podjęcia próby leczenia interferonem
2-alfa. W trakcie leczenia zaobserwowano nieznaczną regresję zmian, a przez następne 6 miesięcy stabilizację choroby.
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Abstract
A 62-year-old, obese woman, smoking 10 pack/year was admitted to the National Tuberculosis and Lung Diseases Research Institute
to diagnose small, round opacities revealed by routine chest X-ray examination. These lesions had been observed for 5 years. The
patient had been treated for psoriasis, hypertension, and insulin-independent diabetes. On admission she was in good condition,
complaining of a slight productive cough as well as intermittent osteoarticular pain. Physical examination revealed cutaneous psoriatic
lesions, slight edema of the lower limbs, and clubbed fingers. Tuberculin test was positive.
Chest Computer Tomography scanning showed partially calcified nodules (up to 1cm in diameter) located in the middle and
base areas of both lungs. No evidence of hilar nor mediastinal lymph node enlargement was seen. Lung specimens displayed
intraalveolar and intravascular growth of neoplastic cells. Immunohistochemical expression of Factor VIII, CD31 and CD34
antigens was present. Pulmonary epithelioid haemangioendothelioma was diagnosed.
After 6 months of observation, progression of the disease was shown. Interferon alpha treatment was introduced. During the
therapy, a slight regression of pulmonary changes was noticed and since then stabilization of the disease was observed.
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The accessory investigations disclosed accelera-
ted ESR (20 mm/hr), elevated blood glucose level (7.48
mmol/l), and Mantoux test of 24 mm with a blister.
The chest X-ray showed numerous pulmonary
nodules of up to 1 cm in diameter predominantly lo-
cated in the lower lung lobes. No evidence of hilar nor
mediastinal lymph node enlargement was seen (Fig. 1).
High Resolution Computer Tomography (HRCT) scan-
ning confirmed the presence of partially calcified le-
sions in the middle and base areas of both lungs (Fig. 2).
Fiberoptic bronchoscopy showed inflamed mucosa
covering a normal tracheobronchial tree. Transbron-
chial lung biopsy was performed and the specimen
disclosed inflammatory infiltrates within the bron-
chial wall. Multiple cultures of sputum and bronchial
secretion were negative for bacteria, acid-fast bacilli,
and fungi. The PCR examination did not reveal the
genetic material of the Mycobacterium tuberculosis.
Cytological evaluation of these samples was negati-
ve. Samples of her stool were examined for eggs of
parasites and also produced negative results. No anti-
bodies against Toxaocara sp. and Toxoplasma sp. were
found, spirometry did not demonstrate any ventilato-
ry disorder, blood gases were normal, exertion test did
not reveal any de-saturation, ultrasound of the abdo-
men was normal, there was no pathology on routine
gynaecological examination, and the mammography
results were within normal limits.
Open lung biopsy was performed in order to
establish a final diagnosis. The lung specimen dis-
Introduction
Epithelioid haemangioendothelioma (EH) is
a rare tumour of mesenchymal origin [1]. It is more
commonly seen in other organs such as the skin,
liver, soft tissues, and bones; occasionally involve-
ment of the lung, mediastinum, and pleura is no-
ticed [2–5]. Approximately 80 cases of pulmonary
involvement have been reported worldwide [3].
Dail et al. (20 cases) and Kitaichi et al. (21 cases)
presented a large series of EHs [4, 5]. Pulmonary
epithelioid haemangioendothelioma (PEH) is usu-
ally manifested radiographically as well-circum-
scribed, multi-centric nodules localized in the
middle and lower parts of the lungs.
It was shown that some antiangiogenic agents,
such as interferon alpha-2a, inhibited proliferation
and migration of endothelial cells [6–9]. Interferon
alpha-2a is a potent angiogenesis inhibitor that acts
by blocking the action of basic fibroblast growth
factor. There has been considerable experience
with the use of interferon alpha-2a in the treatment
of haemangiomas in children and some adults with
haemangioendothelioma [7, 8].
This paper presents a patient with PEH, with
typical localization, who was treated with interfe-
ron alpha-2a. Slight regression of lung lesions was
noticed after a course of interferon alpha-2a treat-
ment and stabilization of the disease was observed
afterwards.
Case report
In May 2003 a 62-year-old, obese woman,
smoking 10 pack/year was admitted to the Natio-
nal Tuberculosis and Lung Diseases Research In-
stitute to diagnose small, round opacities revealed
by a routine chest X-ray examination. These lesions
had been observed for 5 years. The patient had
worked in an office, but in her youth she was em-
ployed in a halogen factory. Her father died of tu-
berculosis 30 years ago, her mother died of a liver
cancer, and her sister of a tongue cancer. The pa-
tient was operated on for left nephrolithiasis at the
age of 28. For many years she has been treated for
psoriasis with cutaneous involvement, and for
3 years for arterial hypertension and insulin-inde-
pendent diabetes.
On admission, the patient had good perfor-
mance status (1-in ECOG scale), complaining of
a slight productive cough as well as intermittent
osteoarticular pain. Physical examination revealed
psoriatic cutaneous lesions on her palms, elbows,
and head, slightly swollen lower limbs, and club-
bed fingers.
Figure 1. Chest X-ray — numerous pulmonary nodules, up to 1 cm
in diameter, located predominantly in the lower lobes of the lungs.
The hilar and mediastinal lymph nodes are not enlarged
Rycina 1. Badanie RTG klatki piersiowej — liczne guzki o średnicy
powyżej 1 cm zlokalizowane w środkowych i dolnych polach płuc-
nych, bez powiększenia węzłów chłonnych wnęk i śródpiersia
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played circumscribed, pale eosinophilic nodules
with central hyalinization, coagulative necrosis
and calcification. The peripheries of the nodules
were more cellular. The balls of tumour tissue
extended to alveolar spaces, bronchioles, blood,
and lymphatic vessels. The neoplastic cells were
cytologically bland with round nuclei and uniform
small-sized nucleoli, without any mitotic activity.
Occasionally, the cells contained sharp single cy-
toplasmic vacuoles thought to represent vascular
lumen differentiations. Expression of FVIII (+),
CD31 (+), and CD34 (+)antigens within neopla-
stic cells were shown in immunohistochemical
examination. Pulmonary epithelioid haemangioen-
dothelioma was diagnosed (Fig. 3, 4).
Six months after open-lung biopsy, progression
of the disease was observed. The interferon alpha-2a
treatment was introduced in a dose of 3 mil U/d,
3 days per week s.c. After 3 months of the therapy
a slight regression of the pulmonary lesions was ob-
served (Fig. 5). However, the patient discontinued
the interferon therapy because of adverse reactions
such as: prostration, chills, elevated temperature,
and musculo-articular pains. During the next
6 months the pulmonary lesions did not deteriorate;
however, after that she was lost from observation.
Discussion
Pulmonary epithelioid haemangioendothelio-
ma (PEH) is a tumour, derived from the endothe-
lium of pulmonary vessels.
The aetiology of this tumour is unknown.
However, different angiogenic stimulators may act
as promoters of the proliferation of endothelial
cells [10]. Recently it was presented that monocy-
Figure 2. HRCT scanning — presence of partially calcified lesions in
the middle and base areas of the lungs
Rycina 2. Tomografia komputerowa wysokiej rozdzielczości — liczne,
częściowo uwapnione guzki w środkowych i dolnych polach płucnych
Figure 3. Histological examination. Pulmonary epithelioid haeman-
gioendothelioma. The central part of the nodule shows hyaline scle-
rosis; at the periphery polypoid extension into adjacent airspaces is
seen (HE, 100 ×).
Rycina 3. Badanie histologiczne — hemangioendothelioma epithe-
lioides płuc. W centrum guzka pole szkliwienia, a na obwodzie
polipowate rozrosty do otaczającego miąższu płuc (HE, 100 ×)
Figure 4. Pulmonary epithelioid haemangioendothelioma — immu-
nohistochemical staining. Positive expression of CD 31 antigen in
the tumour cells (CD31, 200 ×)
Rycina 4. Płucny epithelioid haemangioendothelioma — barwienie
immunohistochemiczne. Komórki guza z dodatnią reakcję na obec-
ność antygenu CD31(CD31, 200 ×)
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te chemo attractant protein-1 (MCP-1) was requi-
red for EH proliferation and might promote the
growth of these lesions by stimulating the angio-
genic behaviour of endothelial cells [9]. Several
clonal abnormalities such as complex unbalanced
translocation between chromosome 7 and 22,
translocation of chromosome 14, and loss of chro-
mosome Y, were also revealed in tumour cells [10].
PEH occurs in more often women, represen-
ting nearly 62–80% of cases presented in the lite-
rature [2–5]. The patients’ ages for the initial exa-
mination ranged between 2 and 76 years, and the
median age for diagnosis ranged from 36 to 42.7
years [2, 3]. There are no characteristic symptoms
of this disease. Over 50–76% of patients are asymp-
tomatic at the time of diagnosis [2, 3]. The most
common symptoms are: chest pain, cough with and
without sputum expectoration, mild dyspnoea, and
occasionally haemoptysis.
The characteristic radiological appearance
consists of multiple, well-defined small nodules up
to 2 cm in diameter localized predominantly in the
lower parts of the lungs. About 60% of cases dis-
played these types of changes. Unilateral opacities,
single and multiple nodular, and “grand glass” at-
tenuations, linear changes, and intralobular sep-
tal thickenings can be also seen. Usually, hilar and
mediastinal lymph nodes are not enlarged. Pleu-
ral effusion is not common, but if it does present,
it is indicative of worse prognosis [2–5]. The lesions
show a slow growth rate and cause progressive
respiratory insufficiency. Our patient was a little
older than the median age of previously observed
female patients [4, 5]. She had mild respiratory
symptoms and clubbed fingers. Dail et al. and Led-
son et al. also observed cases of PAH with this type
of fingers [2, 12]. In our patient, radiological chan-
ges were revealed incidentally 5 years before dia-
gnosis in the form of multiple pulmonary nodules.
The diagnosis of PEH was made on the basis
of the histological features, confirmed by immu-
nohistochemistry results. In this case, histological
examination of the specimen obtained by open-
lung biopsy was typical for the PEH. Neoplasma-
tic cell proliferation with typical immunohistoche-
mical presentation, which is characteristic for en-
dothelial cells, involved alveolar spaces, bronchio-
les, blood, and lymphatic vessels. Cytological aty-
pia and mitotic figures were absent. However, other
authors described some cases of PEH with cytolo-
gical atypia and numerous mitotic figures, which
are symptoms of a worse prognosis [1–5, 12]. Posi-
tive immunohistochemistry staining for endothe-
lial cell markers such as Factor VIII, CD31, and
CD34 confirmed the diagnosis.
During 5-year observation progression of the
disease was rather slow but accelerated after the
open lung biopsy. This was the stimulus for the
introduction of the treatment. Due to the rarity of
the tumour, there is no standard treatment. The
slow progressive course is typical for PEH, and
patients die 2–24 years after diagnosis [2–5, 11–13].
For each individual case it is difficult to predict
a natural history of the disease. In some cases, par-
tial spontaneous regression was observed [2]. Exi-
sting literature recommends different types of treat-
ment: for a solitary nodule, surgical resection
seems to be the treatment of choice, whereas che-
motherapy and radiotherapy proved to be ineffec-
tive. Regimens containing mitomycin C, cyclophos-
phamide, vincristine, cisplatin, 5-fluorouracil,
gemcitabine, docetaxel, and etoposide have been
tested without showing any benefit [2, 3]. Howe-
ver, Pinet et al. observed a complete regression of
pleural epithelioid haemangioendothelioma after
six courses of carboplatin and etoposide chemo-
therapy [14].
In the last few years, antiangiogenic activity
of interferon 2-alphas has been tested in several
clinical situations. There are incidental reports
about the effectiveness of this type of treatment in
PEH patients. Roudier-Pujol et al. described a wo-
man with multifocal epithelioid haemangioendo-
thelioma with pulmonary involvement, in whom
partial remission was achieved after one year of
interferon alpha-2a treatment [7]. In addition, Kay-
ler et al. presented a woman with disseminated
haemangioendothelioma, who was successfully
treated with interferon alpha 2b. In spite of good
Figure 5. HRCT after treatments light regression of pulmonary chan-
ges was seen
Rycina 5. Tomografia komputerowa wysokiej rozdzielczości, bada-
nie po leczeniu — widoczna niewielka regresja zmian guzkowych
w płucach
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results of interferon therapy, she died of graft re-
jection [8]. Kumar et al. reported significant effects
from interferon alpha-2a (3 million units 3 times
per week for 6 months) treatment in a patient with
a mediastinal haemangioendothelioma. This the-
rapy was of benefit and allowed a complete resec-
tion of the tumour [9]. Cronin et al. treated
a 35-year-old woman with PEH, with interferon
alpha-2b, at a dose of 1.5 million units three times
a week. The disease remained stable for a certain
period but afterwards progression was noticed.
Chemotherapy was introduced, but it was ineffec-
tive. The patient died of disease progression [6].
Our patient was treated using interferon alpha-2a
over a 3-month period. This treatment resulted in
a slight regression of pulmonary lesions and sub-
sequently, stabilization of the disease. Due to
adverse reactions, the interferon treatment was
discontinued. Prognosis of this patient is unpre-
dictable. Unfortunately, the patient was lost from
observation.
Conclusion
We presented a rare case of PHE treated with
interferon 2-alpha in which stabilisation of the
disease was observed.
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